---
title: "Edesa Biotech (EDSA.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/EDSA.US/norm.md"
symbol: "EDSA.US"
name: "Edesa Biotech"
parent: "https://longbridge.com/zh-CN/quote/EDSA.US.md"
datetime: "2026-03-05T15:50:40.639Z"
locales:
  - [en](https://longbridge.com/en/quote/EDSA.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/EDSA.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/EDSA.US/norm.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/EDSA.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/EDSA.US/norm.md)


# Edesa Biotech (EDSA.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.2819 | -0.3159 | -0.2491 | -0.2998 | -0.4835 |
| ROE | -229.11% | -220.05% | -124.26% | -166.61% | -396.39% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -2.25M | -2.23M | -1.75M | -1.59M | -1.62M |
| 营业利润 | -2.34M | -2.47M | -1.90M | -1.64M | -1.90M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 14.71M | 13.53M | 14.80M | 16.45M | 4.16M |
| 权益乘数 | 1.05 | 1.09 | 1.05 | 1.06 | 1.84 |
| 每股净资产 | 0.5588 | 0.4469 | 0.6991 | 0.9048 | 0.3699 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 12.05M | 10.79M | 12.36M | 13.90M | 1.56M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | - | - | - | - | - |
| 净债务 | -12.05M | -10.79M | -12.36M | -13.90M | -1.56M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -2.09M | -1.72M | -1.70M | -2.38M | -1.52M |
| 投资现金流 | - | - | - | - | - |
| 融资现金流 | 3.36M | 186483.00 | 0.0000 | 14.77M | 2.07M |
| 自由现金流 | -1.31M | -1.03M | -1.11M | -1.87M | -845254.00 |
| 现金流充裕率 | - | - | - | - | - |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | - | - | - | - | - |